Goodwin Procter advised SWORD Health on the deal.SWORD Health announced the completion of its $85 million Series C funding round led by General Catalyst. Other participating investors…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
